Management of chronic hepatitis C (Chc) genotype 1 treatment-naïve patients in an era of rising opportunities and costs: A cost-effectiveness analysis
Abstract
Data di Pubblicazione:
2014
Tipologia CRIS:
1.5 Abstract in rivista
Keywords:
chronic hepatitis C; cost-effectiveness analysis; quality adjusted life years; incremental cost effectiveness ratio; triple therapy; boceprevir; telaprevir
Elenco autori:
Cortesi, PAOLO ANGELO; Ciaccio, Antonio; Rota, Matteo; De Salvia, S; Okolicsanyi, Stefano; Vinci, M; Belli, L; Lim, J; Mantovani, LORENZO GIOVANNI; Strazzabosco, Mario
Link alla scheda completa:
Pubblicato in: